Response Genetics, Inc
RGDXQ · OTC
12/31/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 | |
|---|---|---|---|---|
| Revenue | $18 | $17 | $20 | $19 |
| % Growth | 7.9% | -15.6% | 5.7% | – |
| Cost of Goods Sold | $14 | $10 | $10 | $10 |
| Gross Profit | $4 | $7 | $9 | $8 |
| % Margin | 21.9% | 40.1% | 47.2% | 44.4% |
| R&D Expenses | $5 | $2 | $2 | $2 |
| G&A Expenses | $15 | $13 | $10 | $9 |
| SG&A Expenses | $20 | $18 | $16 | $14 |
| Sales & Mktg Exp. | $5 | $5 | $5 | $5 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $25 | $20 | $17 | $16 |
| Operating Income | -$21 | -$13 | -$8 | -$8 |
| % Margin | -118.5% | -77.8% | -40.1% | -40.9% |
| Other Income/Exp. Net | $0 | -$1 | $0 | -$0 |
| Pre-Tax Income | -$21 | -$14 | -$8 | -$8 |
| Tax Expense | -$1 | -$0 | -$1 | -$0 |
| Net Income | -$20 | -$14 | -$7 | -$7 |
| % Margin | -111.9% | -81% | -37.8% | -39.3% |
| EPS | -0.52 | -0.35 | -0.22 | -0.28 |
| % Growth | -48.6% | -59.1% | 21.4% | – |
| EPS Diluted | -0.52 | -0.35 | -0.22 | -0.28 |
| Weighted Avg Shares Out | 39 | 39 | 33 | 27 |
| Weighted Avg Shares Out Dil | 39 | 39 | 33 | 27 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $1 | $0 | $0 |
| Depreciation & Amortization | $2 | $1 | $0 | $0 |
| EBITDA | -$20 | -$13 | -$8 | -$7 |
| % Margin | -109% | -77.8% | -40.1% | -38.4% |